RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer	Digestive System Diseases, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, digestive system disorder, epithelial neoplasm, gastroenteritis, mouth disorder, mucositis, neoplasm, squamous cell carcinoma, squamous cell neoplasm, stomatitis	Active, not recruiting	Phase 2	2026-06-26		NCT05966194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
EpicentRx, Inc.	3

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ballad Health	Johnson City	United States	1
Banner Md Anderson Cancer Center	Gilbert	United States	121
East Carolina University School of Medicine	Greenville	United States	1
Miami Cancer Institute	Miami	United States	97
Northwestern University Feinberg School Of Medicine	Chicago	United States	49
Parkview Cancer Institute	Fort Wayne	United States	4
Renown Regional Medical Center	Reno	United States	229
Sandra and Malcolm Berman Cancer Institute	Baltimore	United States	1
The Ohio State University James Cancer Hospital & Solove Research Institute	Columbus	United States	1
The University of Arizona Cancer Center	Tucson	United States	12
University of Michigan	Ann Arbor	United States	538
University of Texas Southwestern Medical Center	Dallas	United States	249
University of Virginia	Charlottesville	United States	122
Willis Knighton Cancer Center	Shreveport	United States	4